1. Home
  2. News
  3. Cellectis S.A.
  4. Monthly information on share capital and company voting rights
More Cellectis S.A. news
Cellectis S.A.EURONEXT: ALCLS

Monthly information on share capital and company voting rights

Nov 4, 2026 · Issued by Cellectis S.A. via Euronext

Filed with Euronext · Nov 4, 2026 · 1 page · English

On 6ix: 6ix.com/news/monthly-information-on-share-capital-and-company-voting-rights-2

Watch Cellectis' latest callCellectis (Euronext:ALCLS) Q1 2026 Earnings Call · Replay · May 11↗

Cellectis S.A. on 6ix

Earlier from Cellectis

  • Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with.HEAL-101 at ESGCT 2026Oct 27
  • Cellectis Announces Strategic Transformation To In Vivo Gene Editing CompanySep 14
  • Cellectis annonce sa transformation stratégique en société d'édition du génome in vivoSep 13
  • Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business UpdateSep 10
  • Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialSep 2

Later from Cellectis

  • Cellectis to Report Third Quarter Financial Results on November 12, 2026Nov 9
  • Cellectis Reports Third Quarter 2026 Financial Results and Provides a Business UpdateNov 13
All Cellectis news releases↗

Follow Cellectis into a list and get an email when it puts out news.

Follow Cellectis
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer